Wockhardt gets USFDA nod for generic anti-bacterial drug

— March 21, 2017 comments off

The application for the product to the US Food and Drug Administration (USFDA) was made by the company’s subsidiary Wockhardt Bio AG, the Mumbai-based company said in a regulatory filing.